Health in Tech, INC Form 4 insider transactions

Health In Tech's CFO, LinLin Qian, was granted 80,000 restricted Class A Common Stock shares, vesting upon key milestones of a new company initiative.

Health In Tech's CFO, LinLin Qian, acquired 27,000 restricted Class A Common Stock shares, increasing her beneficial ownership to over 8 million shares.

Health In Tech, Inc. CEO Tim Donald Johnson was granted 34,000 restricted shares of Class A Common Stock, vesting upon the successful launch of two key company programs.

Health In Tech's Chief Technology Officer, Imran Mohammed Yousuf, was granted 7,000 restricted shares of Class A Common Stock, vesting upon successful program launches.

Health In Tech's Chief Strategy Officer, Jonathan Del Lockett, was granted 7,000 restricted shares of Class A Common Stock, tied to the successful launch of two key company programs.

Health In Tech, Inc. Director William D. Howard was granted 128,474 shares of Class A Common Stock at $0.62 per share as part of the company's Equity Incentive Plan, with vesting tied to service.

Health In Tech, Inc. Director Timothy Hayes has been granted 128,474 restricted shares of Class A Common Stock at a price of $0.62 per share, aligning his interests with the company's performance.

Health In Tech, Inc. Director Sanjay K. Shrestha has acquired 128,474 shares of Class A Common Stock at a price of $0.62 per share, totaling approximately $79,654, as part of the company's Equity Incentive Plan.

Health In Tech, Inc. Director Chike Umemezia was granted 128,474 restricted shares of Class A Common Stock at $0.62 per share, vesting based on service.

Dustin Plantholt, Chief Growth Officer of Health In Tech, Inc., reports acquiring 14,000 shares of Class A Common Stock on March 25, 2025.